Polyhydroxy acids are usually presented as the softer cousin of glycolic and lactic acid. Softer is accurate but incomplete. The molecular size difference does not just dial the intensity down; it changes how deep the molecule travels, how long it takes to produce a visible result, and which skin problems it can address at all. Treating a PHA as a weaker AHA leads to the wrong purchase and the wrong expectations.
What molecular size actually changes
Glycolic acid is the smallest of the common alpha hydroxy acids, with two carbons and a single hydroxyl group. Lactic acid is slightly larger. Gluconolactone, the workhorse PHA, is a six-membered cyclic ester carrying several hydroxyl groups, and lactobionic acid is a disaccharide acid substantially larger than either.
Penetration through the stratum corneum depends on size and on how readily a molecule partitions into the lipid matrix. A larger molecule with many hydrogen-bonding groups moves more slowly, so less of it reaches the viable epidermis at any given time. The exfoliating effect concentrates in the upper layers, where the desmosomes holding corneocytes together are the target anyway.
That is also why the sensory experience differs. Stinging with acids comes partly from penetration into the epidermis and stimulation of nerve endings that sit close to the surface in skin with a compromised barrier. Slower penetration means a flatter irritation curve, which is why many people who cannot tolerate glycolic acid at any useful strength can use gluconolactone nightly.
The trade-off is speed. A PHA produces visible smoothing more slowly than an AHA at the same pH, and it will never match a strong glycolic peel on thick, sun-damaged skin. If you want a dramatic change in two weeks, a PHA will disappoint you. If you want maintenance that does not require recovery days, it is the better instrument.
Beyond exfoliation
Gluconolactone chelates metal ions, which gives it antioxidant behaviour against the iron and copper dependent reactions that generate free radicals. Lactobionic acid has a long history in organ preservation solutions precisely because of its chelating and antioxidant properties, and it holds water well because of the number of hydroxyl groups it carries.
The humectant effect is often overlooked in reviews that focus only on exfoliation. PHAs bind water in the stratum corneum while they loosen corneocytes, so the immediate after-feel is usually softer rather than tight. Some published work suggests PHA formulations support barrier function rather than compromising it, which is unusual for an exfoliant.
Where PHAs lose
Depth is the limitation. A PHA will not reach the sebaceous follicle the way salicylic acid does, because salicylic acid is lipophilic and partitions into sebum. It will not produce the collagen remodelling associated with stronger acids or retinoids. For deep textural scarring or significant photodamage, it is the wrong category of product, not a weaker version of the right one.
Formulation decides most of the outcome. An acid needs to be at a pH where a meaningful fraction is uncharged, and many PHA toners sit near pH 5, where the exfoliating effect is minimal and the product is essentially a humectant with a marketing claim. If the label does not state pH and the texture is watery and non-tingling, assume you are buying hydration rather than exfoliation.
Choosing between them without a hierarchy
For resilient skin with visible texture and no barrier history, an AHA at a moderate strength used two or three nights a week is efficient. For skin that flushes easily, for darker skin tones where post-inflammatory pigment is a real risk, and for anyone already using a retinoid, a PHA fits into the routine with far less scheduling conflict.
They also combine poorly with each other. Alternating an AHA and a PHA on consecutive nights adds irritation without adding benefit, because the second product is doing the same job more gently on skin the first one already treated. Pick one and use it consistently.
Frequency is where most people go wrong regardless of molecule. Two or three nights a week is a maintenance rhythm; nightly use is a treatment rhythm and should be earned over a month rather than started. If a PHA stings on contact at week three, the schedule was too aggressive, not the molecule wrong.
When this is the wrong tool
If the barrier is already compromised, neither acid is appropriate, including the gentle one. Stinging with water is a stop signal regardless of molecule size. If you have rosacea with papules and flushing, acids of any kind can aggravate the vascular component even when they do not sting immediately.
If the goal is clearing cystic acne, closing enlarged pores permanently, or fading deep dermal pigment, no PHA will do it. Those require different mechanisms and, in several cases, a clinician. This is general information rather than medical advice, and persistent texture that does not respond to eight weeks of gentle exfoliation is worth a proper look.